Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Enterprise Value (2022 - 2025)

Envoy Medical's Enterprise Value history spans 4 years, with the latest figure at -$3.6 million for Q3 2025.

  • For Q3 2025, Enterprise Value rose 19.62% year-over-year to -$3.6 million; the TTM value through Sep 2025 reached -$3.6 million, up 19.62%, while the annual FY2024 figure was -$5.5 million, 29.99% down from the prior year.
  • Enterprise Value for Q3 2025 was -$3.6 million at Envoy Medical, up from -$5.3 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$68000.0 in Q2 2023 and bottomed at -$22.2 million in Q3 2023.
  • The 4-year median for Enterprise Value is -$4.2 million (2023), against an average of -$4.5 million.
  • The largest annual shift saw Enterprise Value surged 85.74% in 2023 before it tumbled 2467.65% in 2024.
  • A 4-year view of Enterprise Value shows it stood at -$183000.0 in 2022, then crashed by 2204.92% to -$4.2 million in 2023, then dropped by 29.99% to -$5.5 million in 2024, then soared by 35.14% to -$3.6 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Enterprise Value are -$3.6 million (Q3 2025), -$5.3 million (Q2 2025), and -$5.3 million (Q1 2025).